CME GROUP ($CME) is expected to release its quarterly earnings data on Wednesday, July 23rd before market open, per Finnhub. Analysts are expecting revenue of $1,704,092,876 and earnings of $2.97 per share.
You can see Quiver Quantitative's $CME stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
margin: 24px 0;padding: 20px;
background: linear-gradient(90deg, #c6a3f7 0%, #a8bde3 50%, #7bd4bb 100%);
border: 1px solid #c5e1a5;
border-radius: 10px;
box-shadow: 0 2px 6px rgba(0,0,0,0.08);
text-align: center;
font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;
display: none;
">
Receive $CME Data Alerts
Sign Up
CME GROUP Insider Trading Activity
CME GROUP insiders have traded $CME stock on the open market 24 times in the past 6 months. Of those trades, 4 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $CME stock by insiders over the last 6 months:
- TERRENCE A DUFFY (Chairman and CEO) sold 30,000 shares for an estimated $7,775,400
- JULIE WINKLER (Sr MD Chief Commercial Officer) sold 11,592 shares for an estimated $2,888,378
- HOWARD J SIEGEL sold 10,000 shares for an estimated $2,600,000
- DEREK SAMMANN (Sr MD Gl Hd Commodities Mkts) has made 0 purchases and 2 sales selling 4,650 shares for an estimated $1,304,847.
- KEN VROMAN (Chief Transformation Officer) sold 5,066 shares for an estimated $1,266,500
- LARRY G GERDES has made 0 purchases and 3 sales selling 4,000 shares for an estimated $1,060,441.
- HILDA HARRIS PIELL (Sr MD & Chief HR Officer) sold 3,984 shares for an estimated $997,852
- CHARLES P CAREY has made 0 purchases and 3 sales selling 3,500 shares for an estimated $950,356.
- DEBORAH J LUCAS sold 1,500 shares for an estimated $385,425
- SUZANNE SPRAGUE (COO & Global Head of Clearing) sold 1,500 shares for an estimated $385,249
- PHYLLIS M LOCKETT sold 1,060 shares for an estimated $294,552
- DENNIS SUSKIND sold 1,000 shares for an estimated $271,280
- WILLIAM R SHEPARD has made 4 purchases buying 541 shares for an estimated $144,330 and 0 sales.
- DANIEL G KAYE sold 500 shares for an estimated $141,209
- JONATHAN L MARCUS (Sr MD General Counsel) sold 390 shares for an estimated $108,225
- MARTIN J GEPSMAN sold 300 shares for an estimated $81,951
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CME GROUP Hedge Fund Activity
We have seen 774 institutional investors add shares of CME GROUP stock to their portfolio, and 641 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 2,987,980 shares (+10.1%) to their portfolio in Q1 2025, for an estimated $792,681,214
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,832,475 shares (-34.2%) from their portfolio in Q1 2025, for an estimated $751,427,292
- GQG PARTNERS LLC added 2,176,685 shares (+7676.3%) to their portfolio in Q1 2025, for an estimated $577,452,763
- WELLINGTON MANAGEMENT GROUP LLP added 2,089,935 shares (+370.5%) to their portfolio in Q1 2025, for an estimated $554,438,856
- GAMMA INVESTING LLC removed 1,850,590 shares (-99.6%) from their portfolio in Q2 2025, for an estimated $510,059,615
- JPMORGAN CHASE & CO added 1,780,700 shares (+16.5%) to their portfolio in Q1 2025, for an estimated $472,401,903
- CAPITAL INTERNATIONAL INVESTORS added 1,745,458 shares (+64.9%) to their portfolio in Q1 2025, for an estimated $463,052,552
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CME GROUP Congressional Stock Trading
Members of Congress have traded $CME stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CME stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.
- REPRESENTATIVE CAROL D. MILLER purchased up to $15,000 on 03/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CME GROUP Analyst Ratings
Wall Street analysts have issued reports on $CME in the last several months. We have seen 5 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 07/15/2025
- Oppenheimer issued a "Outperform" rating on 06/04/2025
- UBS issued a "Buy" rating on 04/25/2025
- Morgan Stanley issued a "Overweight" rating on 04/24/2025
- JP Morgan issued a "Underweight" rating on 04/24/2025
- B of A Securities issued a "Underperform" rating on 04/02/2025
- Raymond James issued a "Outperform" rating on 03/10/2025
To track analyst ratings and price targets for CME GROUP, check out Quiver Quantitative's $CME forecast page.
CME GROUP Price Targets
Multiple analysts have issued price targets for $CME recently. We have seen 12 analysts offer price targets for $CME in the last 6 months, with a median target of $291.5.
Here are some recent targets:
- Patrick Moley from Piper Sandler set a target price of $296.0 on 07/15/2025
- Benjamin Budish from Barclays set a target price of $299.0 on 07/10/2025
- Christopher Allen from Citigroup set a target price of $275.0 on 07/03/2025
- Owen Lau from Oppenheimer set a target price of $300.0 on 06/04/2025
- Alex Kramm from UBS set a target price of $305.0 on 04/25/2025
- Kenneth Worthington from JP Morgan set a target price of $211.0 on 04/24/2025
- Kyle Voigt from Keefe, Bruyette & Woods set a target price of $273.0 on 04/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
